Provenienza dei contatti di primo grado di Susan Learned
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
25
| Public Company | Pharmaceuticals: Major | 25 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Susan Learned tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Chief Executive Officer General Counsel Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
| BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ADIAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Reckitt Benckiser Health Ltd.
 Reckitt Benckiser Health Ltd. Medical DistributorsDistribution Services Founded in 2017, Reckitt Benckiser Health Ltd. is a subsidiary of Reckitt Benckiser Group Plc. The company is based in Slough, UK. Reckitt Benckiser Health is home to the world's most loved and trusted hygiene, health, and nutrition brands. | Medical Distributors | Director/Board Member Director/Board Member | |
| IKARIA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director of Finance/CFO Public Communications Contact | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| University of Pennsylvania | College/University | Graduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| University of Michigan | College/University | Graduate Degree | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Sheffield | College/University | Undergraduate Degree | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Baines Peter Consulting | Director/Board Member | ||
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
| Apterna Ltd. | Director/Board Member | ||
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| SMITH & NEPHEW PLC | Medical Specialties | Director of Finance/CFO | |
Millbrook Capital Management, Inc.
 Millbrook Capital Management, Inc. Investment ManagersFinance Millbrook Capital Management, Inc. (Millbrook Capital Management) is a private equity firm founded in 1981 by John S. Dyton. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Chief Executive Officer | |
| King's College London | College/University | Undergraduate Degree | |
| Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree | |
| TENGION, INC. | Biotechnology | Public Communications Contact | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 22 |
| Regno Unito | 20 |
| India | 5 |
| Germania | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Finance | 4 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 155 |
| Corporate Officer/Principal | 64 |
| Independent Dir/Board Member | 60 |
| Chairman | 23 |
| Chief Executive Officer | 19 |
Contatti più connessi
| Insiders | |
|---|---|
| Adrian Hennah | 29 |
| Howard H. Pien | 27 |
| Lizabeth Zlatkus | 24 |
| Juliet Thompson | 22 |
| Peter Bains | 19 |
| Cary Claiborne | 19 |
| Christian Schade | 18 |
| Daniel Tassé | 16 |
| Yvonne Greenstreet | 15 |
| Rupert Bondy | 14 |
| Jerome Lande | 13 |
| Joanna Le Couilliard | 13 |
| Javier Rodriguez | 11 |
| Tatjana Anni Hilde May | 10 |
| Rosh Dias | 10 |
- Borsa valori
- Insiders
- Susan Learned
- Connessioni Società
